News from Sifted

Custom-made gen AI for businesses: Adaptive ML closes $20m seed round

Add to bookmarks Don't show Sifted

Sifted · 03/11/2024 07:38 EDT

Custom-made gen AI for businesses: Adaptive ML closes $20m seed round Read more ›

0

One year after SVB’s fall — who banks founders now?

Add to bookmarks Don't show Sifted

Sifted · 03/11/2024 01:00 EDT

One year after SVB’s fall — who banks founders now? Read more ›

0

49% of founders say they’re considering quitting their startup this year

Add to bookmarks Don't show Sifted

Sifted 1 place · 03/11/2024 01:00 EDT

49% of founders say they’re considering quitting their startup this year Read more ›

5

11 digital therapeutics startups to watch, according to VCs

Add to bookmarks Don't show Sifted

Sifted · 03/11/2024 01:00 EDT

11 digital therapeutics startups to watch, according to VCs Read more ›

0

Exclusive: Griffin raises $24m as it trumpets a fully fledged banking licence

Add to bookmarks Don't show Sifted

Sifted · 03/11/2024 01:00 EDT

Exclusive: Griffin raises $24m as it trumpets a fully fledged banking licence Read more ›

0

All the ways you're wrong about women in VC

Add to bookmarks Don't show Sifted

Sifted 1 place · 03/08/2024 10:38 EDT

All the ways you're wrong about women in VC Read more ›

0

The Angel Code: How to act like the top 1%

Add to bookmarks Don't show Sifted

Sifted 3 place · 03/08/2024 00:00 EDT

The Angel Code: How to act like the top 1% Read more ›

0

Exclusive: Daniel Ek's new bet on longevity

Add to bookmarks Don't show Sifted

Sifted · 03/08/2024 00:00 EDT

Exclusive: Daniel Ek's new bet on longevity Read more ›

0

Healthtech remains on top and UK takes its crown back: February’s seed wrap-up

Add to bookmarks Don't show Sifted

Sifted 2 place · 03/08/2024 00:00 EDT

Healthtech remains on top and UK takes its crown back: February’s seed wrap-up Read more ›

0

Everything you need to know to prepare for the EU’s AI Act

Add to bookmarks Don't show Sifted

Sifted 1 place · 03/07/2024 00:00 EDT

Everything you need to know to prepare for the EU’s AI Act Read more ›

0

5 charts on how female founders and VCs fared in 2023

Add to bookmarks Don't show Sifted

Sifted 2 place · 03/07/2024 00:00 EDT

5 charts on how female founders and VCs fared in 2023 Read more ›

0

5 things UK startups should know about the government’s budget

Add to bookmarks Don't show Sifted

Sifted 3 place · 03/06/2024 10:46 EDT

5 things UK startups should know about the government’s budget Read more ›

0

How to make the most out of hybrid events

Add to bookmarks Don't show Sifted

Sifted 1 place · 03/06/2024 06:00 EDT

How to make the most out of hybrid events Read more ›

99

10 mistakes startups make when talking about sustainability

Add to bookmarks Don't show Sifted

Sifted · 03/06/2024 00:00 EDT

10 mistakes startups make when talking about sustainability Read more ›

0

Defence tech is all the rage but investors have their guard up

Add to bookmarks Don't show Sifted

Sifted · 03/06/2024 00:00 EDT

Defence tech is all the rage but investors have their guard up Read more ›

0

Greenlyte raises €10.5m to reduce cost of carbon removal

Add to bookmarks Don't show Sifted

Sifted 3 place · 03/06/2024 00:00 EDT

Greenlyte raises €10.5m to reduce cost of carbon removal Read more ›

0

UK semiconductor startups' five demands to government ahead of budget

Add to bookmarks Don't show Sifted

Sifted · 03/05/2024 12:16 EDT

UK semiconductor startups' five demands to government ahead of budget Read more ›

0

London-based Limbic raises $14m Series A for its AI chatbot therapist

Add to bookmarks Don't show Sifted

Sifted · 03/05/2024 10:00 EDT

London-based Limbic raises $14m Series A for its AI chatbot therapist Read more ›

0

How to hire inclusively

Add to bookmarks Don't show Sifted

Sifted · 03/05/2024 09:00 EDT

How to hire inclusively Read more ›

0

Cellcolabs raises $8.7m to make stem cells cheaper for novel treatment research

Add to bookmarks Don't show Sifted

Sifted · 03/05/2024 07:22 EDT

Cellcolabs raises $8.7m to make stem cells cheaper for novel treatment research Read more ›

0